Core Insights - Novartis, in collaboration with the Brunei Ministry of Health and EVYD, is launching the CARDIO4Cities project aimed at cardiovascular disease prevention and control using data and AI tools [1][6][9] Group 1: Project Overview - The CARDIO4Cities project will utilize the BruHealth digital health platform to identify high-risk populations and implement targeted interventions to reduce cardiovascular disease risks in Brunei [1][6] - This initiative is part of a broader strategy to transform public health systems from reactive to proactive management, leveraging real-world data for precise health management [6][9] Group 2: Health Statistics and Challenges - Cardiovascular diseases account for over 70% of global deaths, with Brunei facing significant pressure on its public health system due to these diseases being the leading cause of mortality [6][8] - Common challenges in addressing these diseases globally include outdated data infrastructure, fragmented information, and weak monitoring systems, which hinder effective health interventions [6] Group 3: Technological Innovation - The project will employ AI-driven risk stratification for cardiovascular diseases, allowing for differentiated management strategies based on risk levels [6][7] - EVYD's AI capabilities will enhance drug development processes for pharmaceutical companies, improving clinical trial efficiency and cost control [7] Group 4: BruHealth Platform - The BruHealth platform, initially developed for tracking infectious diseases during the pandemic, has evolved into a comprehensive digital infrastructure covering over 85% of Brunei's population [8] - The platform integrates government oversight, healthcare provider tools, and personal health services, becoming a core component of Brunei's health management system [8] Group 5: Global Implications - The collaboration not only offers a new solution for cardiovascular disease management in Brunei but also serves as a model for addressing non-communicable diseases globally [9] - As the project progresses, it is expected to enhance public health services in Brunei and reduce the health and social burdens associated with cardiovascular diseases [9]

Core Insights - Novartis announced a significant collaboration at the 2026 World Economic Forum, focusing on a data-driven cardiovascular disease prevention project called CARDIO4Cities, in partnership with the Brunei Ministry of Health and EVYD, a subsidiary of Yidu Tech [1] - The project aims to leverage the BruHealth digital health platform to identify high-risk populations early and implement precise interventions, thereby reducing the risk of cardiovascular diseases and improving health management in Brunei [1] Group 1: Project Overview - The CARDIO4Cities project is designed to address the high burden of cardiovascular diseases, which are a leading cause of death globally, accounting for over 70% of deaths [8] - In Brunei, cardiovascular diseases are the primary cause of mortality, putting pressure on the public health system [8] - The project will utilize AI to categorize cardiovascular disease risk levels among the population and provide tailored management plans [8][9] Group 2: Technological and Systemic Innovations - The initiative represents a strategic national-level practice aimed at transforming public health systems from reactive to proactive, and from fragmented services to systematic governance [8] - The BruHealth platform, initially developed for tracking infectious diseases during the pandemic, has evolved into a comprehensive digital infrastructure covering over 85% of Brunei's population [10] - The collaboration will enhance data integration, analysis, and technical support for the project, with EVYD playing a key role [10] Group 3: Global Implications - The CARDIO4Cities project has been implemented in over 40 cities worldwide, with previous implementations showing potential to increase blood pressure control rates by 3 to 6 times and reduce stroke incidence by up to 13% [10] - This collaboration not only provides a new solution for cardiovascular disease prevention in Brunei but also serves as a reference model for global non-communicable disease management [11] - The project is expected to significantly improve public health services in Brunei and reduce the health and social burden of cardiovascular diseases [11]